Background: Even though invasive intrauterine techniques for the treatment of TTTS such as punction of amniotic fluid and laser coagulation of placental vascular anastomoses are established methods in specialized centers, invasive methods are not always sufficiently successful. In conservative treatment of TTTS oral or intravenous maternal digoxin therapy in order to improve fetal cardiac insufficiency in combination with or after failure of invasive techniques is an useful method.
Patients And Methods: We investigated 12 TTTS pregnancies and 4 singleton pregnancies, which had been treated by maternal digoxin treatment for TTTS or arrhythmias, respectively. At birth, which was performed by means of caesarian section, venous cord blood samples of the newborns and venous maternal blood samples were collected, centrifugated and stored at minus 20 degrees C. Digoxin determinations were performed by radioimmunoassay.
Results: Fetal digoxin levels varied between 0.38 and 1.73 ng/ml, maternal levels ranged from 0.97 to 3.23 ng/ml. The fetomaternal digoxin gradient reached a mean of 0.56 (range 0.35 to 1.09). Donator and acceptor gradients were comparable and increased with birth weight or gestational week, respectively.
Conclusions: In cases of pregnancies with TTTS a relatively high maternal digoxin level is necessary, especially during early gestational weeks, in order to reach therapeutical levels in the fetal circulation. Too low dosages might be responsible for unfavourable results in digoxin treatment of TTTS. Whether the maturation of placental villi during gestation could be the reason for increasing digoxin gradients requires further investigations.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1055/s-2000-10192 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Differential postnatal cardiovascular course of donor-recipient twins and associated pathophysiology-a cohort study.
Am J Physiol Heart Circ Physiol
December 2024
Monash Newborn, Monash Children's Hospital, Melbourne, Victoria, Australia.
Article Synopsis
- Fetal echocardiography studies show that twins affected by twin-to-twin transfusion syndrome (TTTS) exhibit impaired cardiac function, highlighting a need for further investigation post-birth.
- In a study comparing donor-recipient twin pairs to singleton infants, significant differences in cardiac structure and function were observed, particularly between the recipient twins and singletons.
- The findings indicate that both cardiac function and arterial properties are compromised in TTTS twins, suggesting a necessity for ongoing monitoring after birth to address potential cardiovascular issues.
Predictive Indicators and Outcomes of Pregnancies Affected by Stage I Twin-Twin Transfusion Syndrome Treated With Fetoscopic Laser Photocoagulation.
Prenat Diagn
November 2024
Maternal Fetal Medicine, Osaka Women's and Children's Hospital, Izumi, Japan.
Article Synopsis
- * Out of 272 twin pairs, the survival rates were very high, with 98% of at least one twin surviving and 85% for both, while 93% of recipient twins and 90% of donor twins survived.
- * The research identifies preoperative anemia-polycythemia sequence and arterio-arterial vascular anastomosis (AAA) as significant risk factors for mortality in donor twins after FLP, although the exact mechanisms of AAA need further investigation.
Survival rates in pregnancies complicated by twin-to-twin transfusion syndrome undergoing laser therapy: a systematic review and meta-analysis: Survival rates in twin-to-twin transfusion syndrome.
Am J Obstet Gynecol MFM
October 2024
Fetal Medicine Unit, Saint George's Hospital, London, UK; Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK; Twins and Multiples Centre for Research and Clinical Excellence; Fetal Medicine Unit, Liverpool Women's Hospital, University of Liverpool, Liverpool, UK. Electronic address:
Article Synopsis
- Twin-to-twin transfusion syndrome (TTTS) can cause problems for both babies, and doctors want to understand how severe it is to help with survival rates after treatment.
- They reviewed a lot of studies to see how well both twins survive depending on the severity of TTTS, which is measured in stages.
- The results showed that around 73% of twins survive when TTTS is stage I, but the survival drops to about 48% and 53% for stages III and IV, which are more severe.
Real-time placental vessel segmentation in fetoscopic laser surgery for Twin-to-Twin Transfusion Syndrome.
Med Image Anal
January 2025
Harvard Medical School, Boston, MA, United States of America; Center for Advanced Medical Computing and Simulation, Massachusetts General Hospital, Boston, MA, United States of America. Electronic address:
Article Synopsis
- Twin-to-Twin Transfusion Syndrome (TTTS) affects 15% of identical twins sharing a placenta, and the standard treatment is fetoscopic laser photocoagulation (FLP), which improves fetal survival by correcting abnormal blood vessel connections.
- The proposed solution, TTTSNet, is a network architecture that enhances visualization of placental vessels during FLP surgery, utilizing advanced techniques for accurate vessel segmentation and addressing specific challenges encountered during the procedure.
- Trained on a dataset of video frames from fetoscopic procedures, TTTSNet showed significant performance growth over existing methods, achieving high accuracy and speed, which could enable real-time surgical applications.
Maternal Complications After Laser Surgery for Twin-to-Twin Transfusion Syndrome, a Cohort Study.
Prenat Diagn
November 2024
Division of Fetal Medicine, Department of Obstetrics, Leiden University Medical Center, Leiden, The Netherlands.
Article Synopsis
- The study aimed to evaluate maternal complications following fetoscopic laser surgery (FLS) for twin-to-twin transfusion syndrome (TTTS) from 2008 to 2021.
- A total of 637 mothers underwent FLS, resulting in 1559 reported maternal complications, with severe complications occurring in 8.0% of cases.
- The findings highlight that while FLS is an effective treatment for TTTS, it poses significant risks for mothers, warranting thorough discussions with patients about these risks when considering treatment options.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!